Last Posted: Dec 21, 2020
- Genetic Association between Hypoplastic Left Heart Syndrome and Cardiomyopathies.
Theis Jeanne L et al. Circulation. Genomic and precision medicine 2020 Dec - Assessing the Role of Rare Genetic Variation in Patients With Heart Failure.
Povysil Gundula et al. JAMA cardiology 2020 Dec - Genetic variants associated with therapy-related cardiomyopathy among childhood cancer survivors of African ancestry.
Sapkota Yadav et al. Cancer research 2020 Dec - Angiotensinogen M235T polymorphism and susceptibility to hypertrophic cardiomyopathy in Asian population: A meta analysis.
Zhen Zhen et al. Journal of the renin-angiotensin-aldosterone system : JRAAS 21(4) 1470320320978100 - Neural-Network-Based Diagnosis Using 3-Dimensional Myocardial Architecture and Deformation: Demonstration for the Differentiation of Hypertrophic Cardiomyopathy.
Satriano Alessandro et al. Frontiers in cardiovascular medicine 2020 7584727 - Yield of Rare Variants Detected by Targeted Next-Generation Sequencing in a Cohort of Romanian Index Patients with Hypertrophic Cardiomyopathy.
Micheu Miruna Mihaela et al. Diagnostics (Basel, Switzerland) 2020 Dec 10(12) - 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
et al. Journal of the American College of Cardiology 2020 Nov - 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
et al. Journal of the American College of Cardiology 2020 Nov - Genotype-Phenotype Correlations in Duchenne and Becker Muscular Dystrophy Patients from the Canadian Neuromuscular Disease Registry.
Lim Kenji Rowel Q et al. Journal of personalized medicine 2020 Nov 10(4) - Impact of Genetic Variant Reassessment on the Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy Based on the 2010 Task Force Criteria.
Costa Sarah et al. Circulation. Genomic and precision medicine 2020 Nov
Search Result Summary
- CDC Information (1)
- NIH Information (27)
- CDC Publications (0)
- Human Genome Epidemiologic Studies (838)
- GWAS Studies (11)
- Human Genomics Translation/Implementation Studies (242)
- Genomic Tests Evidence Synthesis (22)
- Genomic Tests Guidelines (15)
- Tier-Classified Guidelines (6)
- Non-Genomics Precision Health (12)
- Pathogen Advanced Molecular Detection (1)
- State Public Health Genomics Programs (5)
- Ethical/Legal and Social Issues (ELSI) (3)
Quick Links to Other Resources
Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Oct 1, 2020
- Page last updated:Dec 28, 2020
- Content source: